Cupping and Serkangabin Versus Conventional Migraine Treatment
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Migraine is the most common recurrent headache. Current therapy of migraine headache consists
of multiple drug groups for control of attack and prophylaxis against recurrent attacks.
Emerging alternative medicine worldwide led investigators to evaluate the efficacy of cupping
therapy plus SERKANGABIN syrup in treatment of migraine headache. Severity, duration and
frequency of attacks of migraine headache evaluated in two groups during six months from
presentation.